Prophage carriage and diversity within clinically relevant strains of Clostridium difficile.
Prophages are encoded in most genomes of sequenced Clostridium difficile strains. They are key components of the mobile genetic elements and, as such, are likely to influence the biology of their host strains. The majority of these phages are not amenable to propagation, and therefore the development of a molecular marker is a useful tool with which to establish the extent and diversity of C. difficile prophage carriage within clinical strains. To design markers, several candidate genes were analyzed including structural and holin genes. The holin gene is the only gene present in all sequenced phage genomes, conserved at both terminals, with a variable mid-section. This allowed us to design two sets of degenerate PCR primers specific to C. difficile myoviruses and siphoviruses. Subsequent PCR analysis of 16 clinical C. difficile ribotypes showed that 15 of them are myovirus positive, and 2 of them are also siphovirus positive. Antibiotic induction and transmission electron microscope analysis confirmed the molecular prediction of myoviruses and/or siphovirus presence. Phylogenetic analysis of the holin sequences identified three groups of C. difficile phages, two within the myoviruses and a divergent siphovirus group. The marker also produced tight groups within temperate phages that infect other taxa, including Clostridium perfringens, Clostridium botulinum, and Bacillus spp., which suggests the potential application of the holin gene to study prophage carriage in other bacteria. This study reveals the high incidence of prophage carriage in clinically relevant strains of C. difficile and correlates the molecular data to the morphological observation.
Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Jinyu
J
Shan
Krusha V
KV
Patel
Peter T
PT
Hickenbotham
Janet Y
JY
Nale
Katherine R
KR
Hargreaves
Martha R J
MR
Clokie
D000900:Anti-Bacterial Agents / Q000378:metabolism; D016360:Clostridioides difficile / Q000145:classification / Q000235:genetics / Q000302:isolation & purification / Q000821:virology*; D003015:Clostridium Infections / Q000382:microbiology; D017931:DNA Primers / Q000235:genetics; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D014644:Genetic Variation; D046529:Microscopy, Electron, Transmission; D008969:Molecular Sequence Data; D017900:Myoviridae / Q000235:genetics / Q000302:isolation & purification; D016133:Polymerase Chain Reaction / Q000379:methods; D039002:Prophages / Q000235:genetics* / Q000302:isolation & purification*; D021521:Ribotyping; D017422:Sequence Analysis, DNA; D017906:Siphoviridae / Q000235:genetics / Q000302:isolation & purification; D014481:United States; D014764:Viral Proteins / Q000235:genetics; D014775:Virus Activation / Q000187:drug effects
D000900:Anti-Bacterial Agents; D017931:DNA Primers; D004269:DNA, Bacterial; D004279:DNA, Viral; D014764:Viral Proteins